Alnylam Pharmaceuticals, Inc.

Alnylam Pharmaceuticals, Inc.

46.40
BRL
-0.68
(-1.44%)
5.17EPS
12.28P/E
174.34BMarket Cap
Feb 18Next Earn

Alnylam Pharmaceuticals, Inc. Documents

Q3 FY2026 · Earnings release

Read Alnylam Pharmaceuticals, Inc.'s results firsthand

Preview the first 2 pages of this earnings release
Create a free account to start reading

Full documents are included with Professional

Q3 FY2026 documents